EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
Gang Xiao(Central South University), Limin Zheng(Weifang University of Science and Technology)
Cited by 183
Related Papers
Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma
|British Journal of Cancer|2018|127
CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms
|Oncotarget|2015|117
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
|Signal Transduction and Targeted Therapy|2021|101
Cholinergic macrophages promote the resolution of peritoneal inflammation
|Proceedings of the National Academy of Sciences|2024|14